Literature DB >> 22253516

Role of genetics in the diagnosis and prognosis of Crohn's disease.

Epameinondas V Tsianos1, Konstantinos H Katsanos, Vasileios E Tsianos.   

Abstract

Considering epidemiological, genetic and immunological data, we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment interact to produce the disease. It is probable that patients have a genetic predisposition for the development of the disease coupled with disturbances in immunoregulation. Several genes have been so far related to the diagnosis of Crohn's disease. Those genes are related to innate pattern recognition receptors, to epithelial barrier homeostasis and maintenance of epithelial barrier integrity, to autophagy and to lymphocyte differentiation. So far, the most strong and replicated associations with Crohn's disease have been done with NOD2, IL23R and ATG16L1 genes. Many genes have so far been implicated in prognosis of Crohn's disease and many attempts have been made to classify genetic profiles in Crohn's disease. CARD15 seems not only a susceptibility gene, but also a disease-modifier gene for Crohn's disease. Enriching our understanding on Crohn's disease genetics is important but when combining genetic data with functional data the outcome could be of major importance to clinicians.

Entities:  

Keywords:  Crohn’s; Diagnosis; Genetic consortium; Genetics; Genome wide scan; Polymorphism; Prognosis

Mesh:

Substances:

Year:  2012        PMID: 22253516      PMCID: PMC3257437          DOI: 10.3748/wjg.v18.i2.105

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  145 in total

1.  Gut microbes, the innate immune system and inflammatory bowel disease: location, location, location.

Authors:  Edgar C Boedeker
Journal:  Curr Opin Gastroenterol       Date:  2007-01       Impact factor: 3.287

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

3.  Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.

Authors:  Julia Dambacher; Tanja Staudinger; Julia Seiderer; Zeljka Sisic; Fabian Schnitzler; Simone Pfennig; Katrin Hofbauer; Astrid Konrad; Cornelia Tillack; Jan-Michel Otte; Joachim Diebold; Burkhard Göke; Thomas Ochsenkühn; Peter Lohse; Stephan Brand
Journal:  Inflamm Bowel Dis       Date:  2007-01       Impact factor: 5.325

4.  Gastroduodenal Crohn's disease is associated with NOD2/CARD15 gene polymorphisms, particularly L1007P homozygosity.

Authors:  Houssam E Mardini; Kalvin J Gregory; Munira Nasser; Lisbeth Selby; Razvan Arsenescu; Trevor A Winter; Willem J S de Villiers
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 5.  Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.

Authors:  S Vermeire
Journal:  Aliment Pharmacol Ther       Date:  2006-10       Impact factor: 8.171

6.  The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease.

Authors:  D Thalmaier; J Dambacher; J Seiderer; A Konrad; V Schachinger; S Pfennig; J-M Otte; A Crispin; B Göke; T Ochsenkühn; P Lohse; S Brand
Journal:  Aliment Pharmacol Ther       Date:  2006-10-01       Impact factor: 8.171

7.  Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.

Authors:  M Alvarez-Lobos; J I Arostegui; M Sans; D Tassies; J Piu; J C Reverter; J M Pique; J Yagüe; J Panés
Journal:  Aliment Pharmacol Ther       Date:  2007-02-15       Impact factor: 8.171

Review 8.  Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?

Authors:  Graham Radford-Smith; Nirmala Pandeya
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

9.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

10.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.

Authors:  Jochen Hampe; Andre Franke; Philip Rosenstiel; Andreas Till; Markus Teuber; Klaus Huse; Mario Albrecht; Gabriele Mayr; Francisco M De La Vega; Jason Briggs; Simone Günther; Natalie J Prescott; Clive M Onnie; Robert Häsler; Bence Sipos; Ulrich R Fölsch; Thomas Lengauer; Matthias Platzer; Christopher G Mathew; Michael Krawczak; Stefan Schreiber
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

View more
  22 in total

1.  Family history in early-onset inflammatory bowel disease.

Authors:  Anna Monica Bianco; Valentina Zanin; Lorenzo Monasta; Stefano Martelossi; Annalisa Marcuzzi; Sergio Crovella
Journal:  J Gastroenterol       Date:  2012-08-11       Impact factor: 7.527

Review 2.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

3.  JAK2 rs10758669 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.

Authors:  Ji-Xiang Zhang; Jia Song; Jun Wang; Wei-Guo Dong
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

4.  Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort.

Authors:  Maneesha Bhullar; Finlay Macrae; Gregor Brown; Margie Smith; Ken Sharpe
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 5.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 6.  Do bugs control our fate? The influence of the microbiome on autoimmunity.

Authors:  Irene Fung; Jackie P-D Garrett; Anupama Shahane; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

7.  Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.

Authors:  Diana Lacruz-Guzmán; Daniel Torres-Moreno; Francisco Pedrero; Patricia Romero-Cara; Iván García-Tercero; Javier Trujillo-Santos; Pablo Conesa-Zamora
Journal:  Eur J Clin Pharmacol       Date:  2012-09-08       Impact factor: 2.953

Review 8.  MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.

Authors:  Mehmet Coskun; Jacob Tveiten Bjerrum; Jakob Benedict Seidelin; Ole Haagen Nielsen
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

9.  ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Authors:  Gary R Lichtenstein; Edward V Loftus; Kim L Isaacs; Miguel D Regueiro; Lauren B Gerson; Bruce E Sands
Journal:  Am J Gastroenterol       Date:  2018-03-27       Impact factor: 10.864

Review 10.  An update on granulomatous diseases of the oral tissues.

Authors:  Faizan Alawi
Journal:  Dent Clin North Am       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.